Reports for ASPEN PHARMACARE CANADA INC.

Company Name

ASPEN PHARMACARE CANADA INC.

Totals

Shortage reports

191

Actual shortage: 8 (4%)
Anticipated shortage: 14 (7%)
Avoided shortage: 36 (19%)
Resolved: 133 (70%)

Discontinuation Reports

2

To be discontinued: 0 (0%)
Discontinued: 2 (100%)
Reversed: 0 (0%)

Late reports

16 (8%)

Overdue reports

4 (18%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 0.005MG 20MG SOLUTION Resolved 2022-03-02 2022-04-27 155852
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 0.005MG 20MG SOLUTION Resolved 2022-05-06 2022-06-24 160123
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 0.005MG 20MG SOLUTION Resolved 2022-08-04 2023-02-02 166122
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 0.005MG 20MG SOLUTION Resolved 2023-02-06 2024-01-04 183684
FRAXIPARINE 9500UNIT SOLUTION Resolved 2018-07-24 2020-04-29 56331
FRAXIPARINE 9500UNIT SOLUTION Resolved 2020-04-06 2020-05-19 111066
FRAXIPARINE 9500UNIT SOLUTION Resolved 2021-01-04 2021-04-27 130817
ARIXTRA 12.5MG SOLUTION Resolved 2018-07-24 2020-04-29 56322
ARIXTRA 12.5MG SOLUTION Resolved 2018-07-24 2020-04-29 56325
MYLERAN 2MG TABLET Resolved 2018-04-25 2018-07-25 47182
MYLERAN 2MG TABLET Resolved 2019-11-25 2020-01-23 99609

Showing 181 to 191 of 191

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ELTROXIN 300MCG TABLET Discontinued 2020-04-29 2020-04-29 113481
IMURAN 50MG POWDER FOR SOLUTION Discontinued 2020-11-20 2021-04-08 128667

Showing 1 to 2 of 2